Bi Asset Management Fondsmaeglerselskab A Corcept Therapeutics Inc Transaction History

Bi Asset Management Fondsmaeglerselskab A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $48,026 - $63,622	1,935 Added 17.73%	12,851 $417,000
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $239,824 - $368,960	10,916 New	10,916 $297,000
Q1 2023 May 12, 2023	BUY	$19.2 - $24.47 $1.94 Million - $2.47 Million	101,017 New	101,017 $2.19 Million
Q3 2021 Nov 09, 2021	SELL	$19.68 - $22.53 $3.05 Million - $3.49 Million	-154,761 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$19.97 - $24.43 $927,067 - $1.13 Million	46,423 Added 42.85%	154,761 $3.41 Million
Q1 2021 May 10, 2021	BUY	$23.49 - $30.56 $2.54 Million - $3.31 Million	108,338 New	108,338 $2.58 Million

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.